Latest news for Aker Horizons (OTC:AKHOF) Stock

Aker Horizons ASA is an investment management company. It invests in and develops companies within renewable energy sectors and other technologies that make material contributions to reducing emissions or promoting sustainable living. The company's reportable segments are Aker Carbon Capture (ACC), Asset Development (AAD), Mainstream Renewable Power (Mainstream), Aker Horizons and holdings, and Others.

Aker Horizons ASA

Arm Holdings Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) shares are trading lower Wednesday alongside several semiconductor stocks following <a href="https://www.benzinga.com/pressreleases/24/07/g39808190/asml-reports-6-2-billion-total-net-sales-and-1-6-billion-net-income-in-q2-2024">soft guidance from ASML</a>.
What Happened With ASML: ASML Holding N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) reported second-quarter sales of €6.242 billion ($6.82 billion),&nbsp;which beat analyst estimates of €6.032 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>. The company reported second-quarter earnings of €4.01 per share, which beat analyst estimates of €3.71 per share.
Despite beating analyst estimates on the top and bottom lines, ASML issued weak guidance for the third quarter. The company said it expects third-quarter net sales of €6.7 billion to €7.3 billion versus estimates of €7.608 billion. ASML also guided for third-quarter gross margin between 50% and 51%. 
&#8220;We see 2024 as a transition year with continued investments in both capacity ramp and technology. We currently see strong developments in AI, driving most of the industry recovery and growth, ahead of other market segments,&#8221; said Christophe Fouquet, president and CEO of ASML.
Why It Matters: Arm Holdings is due to report financial results for its fiscal first quarter on July 31. The company is expected to report earnings of 34 cents per share and revenue of $903.573 million, according to estimates from <a href="http://pro.benzinga.com">Benzinga Pro</a>. 
Last quarter, Arm beat analyst estimates on the top and bottom lines and introduced guidance for fiscal year 2025. The company noted at the time that it had strong tailwinds heading into the year driven by increased demand for Arm-based technology &#8220;across all end markets.&#8221;
&#8220;From cloud to edge, all AI software models, from GPT to Llama, rely and run on the Arm compute platform. As these models become larger and smarter, their requirements for more compute with greater power efficiency can only be realized through Arm,&#8221; CEO Rene Haas said. 
See Also: <a href="https://www.benzinga.com/markets/equities/24/07/39813495/why-key-apple-nvidia-supplier-tsmcs-shares-are-plunging-in-wednesdays-premarket">Why Key Apple, Nvidia Supplier TSMC&#8217;s Shares Are Plunging</a>
ARM Price Action: Arm shares were down 4.30% at $171.09 at the time of publication, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

News

Movers

ASML

What's Going On With Arm Holdings Stock Wednesday?

Workhorse Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKHS#NASDAQ">WKHS</a>) shares appear to be moving higher on continued momentum Wednesday after the stock rallied 26% on Tuesday after Workhorse was awarded a contract for <a href="https://www.benzinga.com/news/24/07/39799765/whats-going-on-with-workhorse-group-stock-tuesday">zero-emission commercial vehicles</a>.
What Happened: Workhorse on Tuesday said it was awarded a Sourcewell contract for procurement in the category of Class 4-8 chassis and cabs with related equipment, accessories and services. The achievement allows Workhorse to expand its reach to government, educational and nonprofit sectors within all 50 states and Canada.
Sourcewell is a government agency created by the Minnesota legislature as a local unit of government. As an awarded contract supplier, Workhorse is now approved to serve Sourcewell&#8217;s network of members.
&#8220;Sourcewell&#8217;s streamlined purchasing process satisfies the legal requirement of the traditional bidding process, enabling our customers to quickly and efficiently acquire zero-emission vehicles that meet their operational requirements,&#8221; said Ryan Gaul, president of commercial vehicles at Workhorse.
&#8220;Municipalities across the nation are leading the way in the transition to zero-emissions fleets and this contract will allow Workhorse to work with them efficiently to deploy the vehicles they need to meet their plans.&#8221;
Check This Out: <a href="https://www.benzinga.com/news/24/07/39778389/automotive-stocks-like-lucid-and-peers-are-trading-lower-on-monday-whats-going-on">Automotive Stocks Like Lucid And Peers Are Trading Lower On Monday &#8211; What&#8217;s Going On?</a>
<h2 class="wp-block-heading">How To Buy WKHS Stock</h2>
By now you're likely curious about how to participate in the market for Workhorse &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. In the case of Workhorse, which is trading at $2.08 as of publishing time, $100 would buy you 48.08 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
WKHS Price Action: Workhorse shares closed Tuesday up 26.1%. The stock was up another 8.17% Wednesday morning, hovering around $2.25 at the time of publication, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: courtesy of Workhorse.

WKHS

What's Going On With Workhorse Stock Wednesday?

Shares of value retailer Five Below Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) are diving Wednesday after the company announced a CEO transition and provided updated guidance for the second quarter. Multiple analysts downgraded the stock and slashed price targets <a href="https://www.benzinga.com/analyst-stock-ratings">following the announcements</a>.
What To Know: Five Below announced that&nbsp;Joel Anderson&nbsp;stepped down from his roles as president and CEO to pursue other interests.&nbsp;Anderson will also step down from the company's board.
COO&nbsp;Kenneth Bull&nbsp;has been named interim president and CEO, effective immediately. Five Below co-founder, non-executive chairman and former CEO&nbsp;Thomas Vellios&nbsp;will assume the role of executive chairman on an interim basis to support the executive leadership team while the board looks for a permanent CEO.
Five Below also announced that total sales for the 10 weeks ending July 13 increased 9.5% on a year-over-year basis, but said comparable sales fell 5%.
As a result, the company now expects second-quarter sales of $820 million to $826 million and anticipates a 6% to 7% decrease in comparable sales. Diluted income per common share is expected to be in the range of 53 cents to 56 cents per share.
Related Link: <a href="https://www.benzinga.com/news/24/07/39814195/amazon-to-rally-around-9-here-are-10-top-analyst-forecasts-for-wednesday">Amazon To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday</a>
Analyst Changes:
<ul>
<li>Morgan Stanley analyst Simeon Gutman downgraded Five Below from Overweight to Equal-Weight and lowered the price target from&nbsp;$160&nbsp;to&nbsp;$100.</li>
</ul>
<ul>
<li>Truist Securities analyst Scot Ciccarelli downgraded Five Below from Buy to Hold and lowered the price target from&nbsp;$136&nbsp;to&nbsp;$89.</li>
</ul>
<ul>
<li>Evercore ISI Group analyst Michael Montani downgraded Five Below from Outperform to In-Line and lowered the price target from&nbsp;$160&nbsp;to&nbsp;$113.</li>
</ul>
<ul>
<li>Mizuho analyst David Bellinger downgraded Five Below from Outperform to Neutral and lowered the price target from&nbsp;$150&nbsp;to&nbsp;$85.</li>
</ul>
<ul>
<li>BofA Securities analyst Melanie Nunez maintained Five Below with a Neutral and lowered the price target from&nbsp;$125&nbsp;to&nbsp;$104.</li>
</ul>
FIVE Price Action:&nbsp;<a href="https://www.benzinga.com/quote/FIVE" target="_blank" rel="noreferrer noopener">Five Below shares</a>&nbsp;were down 14.3% at $87.52 at the time of publication, according to&nbsp;<a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Photo: &nbsp;<a href="https://www.flickr.com/photos/jeepersmedia/" target="_blank" rel="noreferrer noopener">Mike Mozart</a>&nbsp;from Flickr.

Downgrades

Price Target

FIVE

Five Below Stock Is Tumbling Wednesday: What's Driving The Action?

European Aeronautic Defence And Space Unsponsored

EADSY

Yemen Airways Signs Pact With Airbus To Purchase 8 Aircraft

Macro Economic Events

Economics

Federal Reserve

Fed's Barkin Says Clearly On The "Back End" Of Inflation; Firms Are Still Trying To Test Their Pricing Power, Though That Is Not A Permanent State; Possible That Monetary Policy Impacts Are Slower To Be Felt Than Before; Watching Unemployment Rate Carefully, But Also Open To Idea That Policy Is Not As Restrictive As Thought

<ul>
<li>On Tuesday, July 16, 2024, the California Alternative Energy and Advanced Transportation Financing Authority (CAEATFA) approved an award involving sales and use tax exclusion incentives related to Archer's planned advanced manufacturing project in the State of California</li>
<li>This award, which is believed to be CAEATFA's largest to date in the advanced air mobility industry, will support Archer's planned expansion of its state-of-the-art electric powertrain and aircraft production facilities intended to support its commercialization</li>
<li>Archer was selected after a highly competitive application process that looked closely at the project's impact on the environment, its ability to create jobs and stimulate economic activity, and its categorization as a strategic emerging industry</li>
</ul>

Contracts

ACHR

Archer Aviation Granted $117M Award For Ramp Of Its Electric Powertrain Facility By California's Alternative Energy And Advanced Transportation Financing Authority

Plumas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLBC#NASDAQ">PLBC</a>) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1.09 by 4.59 percent. This is a 1.79 percent increase over earnings of $1.12 per share from the same period last year. The company reported quarterly sales of $20.61 million which beat the analyst consensus estimate of $20.00 million by 3.04 percent. This is a 6.32 percent increase over sales of $19.38 million the same period last year.

Earnings

PLBC

Plumas Q2 EPS $1.14 Beats $1.09 Estimate, Sales $20.61M Beat $20.00M Estimate

Elevance Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">consensus of $43.05 billion</a>. 
The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend and growth in CarelonRx product revenue <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/b39810749/elevance-health-reports-second-quarter-2024-results" rel="noreferrer noopener">related to members served</a>.
Related: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39463362/morgan-stanley-says-elevance-healths-growth-attributed-to-consistent-performance-bu" rel="noreferrer noopener">Morgan Stanley Says Elevance Health&#8217;s Growth Attributed To Consistent Performance But Undervalued</a>.
Premiums fell 3.2% to $35.42 billion, and product revenue rose 14% to $5.53 billion. Services fees increased 18% to $2.28 billion.
&#8220;Second quarter results reflect the power of our diversified business and thoughtful execution of our strategic initiatives during a dynamic time for our industry, as we remain steadfast in our purpose to improve the health of humanity. We have prudently maintained our full-year outlook and are confident in the earnings power of our Health Benefits and Carelon businesses, which underpin our long-term targets,&#8221; said Gail Boudreaux, President and CEO.
Profit rose 24% to $2.3 billion, or $9.85 a share. Per-share adjusted earnings reached $10.12, beating consensus of $10.01.
The benefit expense ratio was 86.3%, an improvement of 10 basis points, driven primarily by premium rate adjustments to cover medical cost trends in the Health Benefits business and disciplined commercial underwriting.
Medical membership totaled approximately 45.8 million, a decrease of 5% compared to the prior year quarter, driven by attrition in Medicaid business associated with eligibility redeterminations and footprint adjustments, primarily in the first quarter.
Medicaid enrollment dropped 23% to 9 million in the second quarter compared to 11.7 million a year ago.
These losses were partially offset by growth in Affordable Care Act health plans and commercial Employer Group fee-based membership.
Reuters notes that Unlike rivals UnitedHealth Group Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) and Humana Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>), Elevance is less exposed to government-backed Medicare Advantage plans for people aged 65 and older and banks more on commercial and Medicaid health plans.
Operating revenue at its Carelon division was $13.3 billion, up by 10% year-over-year.
Guidance: Elevance Health expects GAAP net income per diluted share of at least $34.05 in 2024 and reaffirms adjusted EPS guidance of at least $37.20 versus <a target="_blank" href="https://www.benzinga.com/news/earnings/24/04/38315332/elevance-health-clocks-2-2b-q1-net-profit-despite-21-drop-in-medicaid-enrollment-lifts-annual-guida" rel="noreferrer noopener">consensus Of $37.28</a>.
Price Action: ELV shares are down 3.82% at $532.00 during the premarket session on the last check Wednesday.
Image: Shutterstock/ REDPIXEL.PL
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39813647/johnson-johnsons-q2-earnings-revenue-and-profit-beat-on-strong-pharma-sales-annual-profit-outlook" target="_blank" rel="noreferrer noopener">Johnson &amp; Johnson&#8217;s Q2 Earnings: Revenue And Profit Beat On Strong Pharma Sales, Annual Profit Outlook Lowered On M&amp;A Costs</a></li>
</ul>

Equities

Large Cap

Guidance

Health Care

Trading Ideas

General

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Elevance Health Beat Street Estimates On Q2 Profit And Revenue, Sticks To Annual Guidance

Specialty cancer diagnostics company <a href="https://www.globenewswire.com/Tracker?data=bOQ6DTUomxapsrUub6PGLqNkn1fW5K7j-ga3UsyVZ39ADXUUv7ylclC4rtQRoPXEXWOGfmCWIA7UyDdXZsl1Tn7lwltHTZD-KumoCCsOcr1LZGGw7FBYlQvhv8rZ1Gl4vE65e4Wz8aNtVBC81IDF6qwOE202Zgq622gob3E4lP3NTSHxrn0mf7TLS9jwdhZ-VV8fnBbKtxSr4bzm9zhDb0Dk2U5hWd5hgzzE-LIaAJagmyL28Wdatxsg3uHyKX-aMfoFwj61xhjlMe_HYF2J5d82dOjk-l36gXtySmVW32OPPdbBIcUJ_Ww6lc0Su4KdCmU_zCrrTyrpYzLV--6OCGFXmZhecCiocjDmwEMCWkaJCBn27BXt4F9nZrBkvlxojCVhkb9yp7TPnUingy9UOw==">Precipio, Inc.</a> <a href="https://www.globenewswire.com/Tracker?data=N21q3k9_37yvSjkA_PcScRVjqCoekXdn7Qy0OCbQTr3MvsozU8PW_ZcNJ3niGDCFat1n3yeptT2P6gaG2uyDgPzWocmRWF1dVpOd60AksH5Ap-p8U81eT735arFs69MfnLLJz_7FDq6cFSl6adkvAxPUThXeQs4T93DeuMs7gobYpdC1-Sfl_FVlcLHn6Ghux-Tq_wBo2suTJPGJWwrefXpRDk8R8m4COPMZJxTK3XEF7XBG-HjQnG8AYR7VWwho7x8bsLzSCNrfMODISJKsdd13vd-3s5WReFd_5IQwGPfbLNTDUEYdIwWTISOHnAoSgy5IKWrOPR6-JSHQtKpexZ1SKlQ4D0jH9q2UHEbdCN-DaZyQDzRYL1_fqyoWcoq9wWTk6Sg1wwzK8Z0hAHuyUw==">(NASDAQ:</a><a href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>), announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. &nbsp;
Pathology Division revenue in June reached its breakeven point, and the company anticipates continued growth in the next few months. We expect this division's revenues will reach more than $1.5 million per month by year end, well above its breakeven goals.

PRPO

Precipio Reports Q2 2024 Revenue Of $4.4M Vs $4.33M Est; Expects Pathology Division's Revenues Will Reach More Than $1.5M Per Month By Year End

Susquehanna analyst Christopher Rolland maintains Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) with a Positive and raises the price target from $205 to $250.

Analyst Ratings

Susquehanna Maintains Positive on Texas Instruments, Raises Price Target to $250

<ul>
<li>Significant financial and programmatic investments in support of critical economic priorities including housing affordability, no-fee banking access, and small business growth</li>
<li>Includes $44 billion in community development financing, $600 million in support for Community Development Financial Institutions, $575 million in philanthropy, $200 billion in consumer lending to low- and moderate-income (LMI) consumers or consumers in LMI communities, $15 billion in lending to small businesses, and $5 billion in anticipated spending with diverse suppliers</li>
<li>Plan will be more than twice as large as any community commitment previously developed in connection with a bank acquisition
<ul>
<li>Innovative approach brought together a coalition of four leading community groups to negotiate and develop the comprehensive package of community-focused solutions</li>
</ul>
</li>
</ul>

Capital One Announces Five-Year, $265B Community Benefits Plan In Connection With Discover Acquisition

Fed's Barkin Says Firms Reluctant To Let People Go, Some Sectors Still Short On Labor Supply; Inflation Has Decreased Over The Last Quarter

AMAT, AMD, AMKR, ARM, AVGO, KLAC, LRCX, MRVL, MU, NVDA, TSM

WIIM

AMAT

AMKR

AVGO

KLAC

LRCX

MRVL

NVDA

Shares of semiconductor stocks are trading lower amid reports Biden is considering further China restrictions. The sector may also be down following soft guidance from ASML.

The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list.
Hyperfine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPR#NASDAQ">HYPR</a>), the groundbreaking medical device company that has redefined brain imaging with the world's first FDA-cleared portable magnetic resonance brain imaging system—the Swoop&#xAE; system—today announced the clearance of the ninth generation of AI-powered Swoop&#xAE; system software. This advanced software significantly reduces scan times across multiple MR sequences without sacrificing image quality. The U.S. Food and Drug Administration (FDA) clearance of this software further solidifies Hyperfine as a leader in AI-powered health technology.
These scan time reductions may enable Swoop&#xAE; system images to help speed up the diagnostic process in acute care settings, which is crucial for time-sensitive medical conditions such as stroke, where every second counts. Reducing the overall acquisition time for sequences can also decrease the negative impact of patient motion on image quality.

Biotech

HYPR

Hyperfine Announces FDA Clearance Of Software Update That Enables Faster Acquisition Of Best-In-Class Ultra-Low-Field Brain Images

Susquehanna analyst Christopher Rolland maintains Skyworks Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKS#NASDAQ">SWKS</a>) with a Neutral and raises the price target from $90 to $125.

SWKS

Susquehanna Maintains Neutral on Skyworks Solutions, Raises Price Target to $125

ASML CEO Fouquet Says China Opportunity Remains Significant; Refuses To Comment On Rumors Of US Push For China Curbs

Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), today announced the availability of the Crucial&#xAE; P310 2230 Gen4 NVMe&#x2122; solid-state drive (SSD), which empowers enthusiasts of handheld gaming and users of mini PCs and ultrathin laptops to store more games and data-intensive content at their fingertips without sacrificing speed or performance. With read and write speeds of 7,100 and 6,000 megabytes per second (MB/s), respectively,1 and capacities up to 2 terabytes (TB), the P310 2230 SSD packs a unique punch, offering high performance and capacity in a compact, power-efficient form factor. &nbsp;

Micron Unveils Industry's Fastest 2230 Gen4 Consumer SSD, The Crucial P310, To Accelerate Handheld Gaming, Ultrathin Laptops And Mini PCs

In a rapidly growing industry fraught with unique challenges, cannabis businesses must master the art of risk management to ensure long-term success. At Benzinga&#8217;s recent <a href="https://www.youtube.com/watch?v=vH8j0EUGIr4">Cannabis virtual event, Titans In Finance,</a> industry expert Henry Miller, vice president of originations at Pelorus Capital Group, shared essential strategies for navigating the <a href="https://www.benzinga.com/crypto">complex cannabis market.</a>
Evaluating Market Conditions
Miller emphasized the critical importance of thorough market evaluation. &#8220;It&#8217;s important to balance immediate capital needs with sustainable strategies for growth,&#8221; he stated. Without a deep understanding of both current market conditions and potential future developments, businesses may struggle to survive.
Miller highlighted the unique complexity of the cannabis industry, where state-specific regulations and market dynamics can significantly impact operations. &#8220;When assessing risk, you need to track what&#8217;s online or coming online in each individual state. The reality is, in another industry, if you start a business, you&#8217;re a U.S. company. In cannabis, you are very state-specific.&#8221;
Geographic and Market-Specific Analysis
A key takeaway from Miller&#8217;s discussion was the importance of geographic and market-specific analysis. Cannabis ventures must consider the distinct regulatory environments and market demands of the states in which they operate. &#8220;You need to underwrite your business to what it might be doing two years from now, making sure that you are still positive cash flow at that point,&#8221; Miller advised.
He noted that while new markets might present significant opportunities, they also come with inherent risks. &#8220;Look at where the state you operate in is in its lifecycle. Who would you be competing against, and when are they coming online?&#8221; Understanding these dynamics can help businesses better navigate the complex environment of the cannabis industry.
Balancing Capital Needs and Long-Term Viability
Miller also discussed the importance of balancing immediate capital needs with long-term viability. He pointed out that while securing capital is crucial, ensuring that the chosen capital structure supports sustainable growth is equally important. &#8220;There&#8217;s an optimal capital structure where if you take on the wrong type of financing, it may work in the short term, but long term, it doesn&#8217;t set your business up for success,&#8221; he explained.
By focusing on a balanced approach to financing, cannabis businesses can better position themselves to weather market fluctuations and achieve sustained success. This approach involves carefully considering the equity and debt financing mix to support current operations and future expansion.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/07/39814550/biden-blasts-trump-at-naacp-convention-touts-dems-cannabis-reforms-as-race-tightens">Biden Blasts Trump At NAACP Convention, Touts Dems Cannabis Reforms As Race Tightens</a></li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Titans of Finance! &#x7C; Benzinga Cannabis Insider [SPECIAL]" width="500" height="281" src="https://www.youtube.com/embed/vH8j0EUGIr4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<hr class="wp-block-separator has-alpha-channel-opacity" />
Cannabis rescheduling seems to be right around the corner. Want to understand what this means for the future of the industry? Hear directly from top executives, investors, advocates, and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a>&nbsp;before prices surge by following&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.
Image: Shutterstock

Cannabis

Topics

Events

Exclusives

Are You Overlooking Critical Market Analysis In Your Cannabis Investments?

Following the recent news of <a href="https://www.kartoonchannel.com/">Kartoon Channel's</a> continued profitability and paid subscriber growth trend in the U.S., <a href="https://www.kartoonstudios.com/">Kartoon Studios'&nbsp;</a>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOON#NYSE">TOON</a>) announces the further expansion of the service outside the U.S., with its launch on a leading provider of high-speed next generation broadband ("NGBB") and cable TV in Indonesia, <a href="https://www.linknet.co.id/">Link Net</a> (LINK.JK), reaching a potential audience of nearly 300 million in the world's fourth most populous country.

Global

TOON

Kartoon Channel Worldwide Continues Expansion Of Global Footprint, Now Available In 57 Territories With Audience Reach Of ~1.6B People

Under the MOR-EV program, the Mullen ONE Class 1 EV cargo van, with a suggested MSRP of $34,500, is now approved for a MA state cash rebate of up to $3,500
When combined with the available $7,500 federal tax credit, the net effective cost of the Mullen ONE would be approximately $23,500
BREA, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- via IBN -- <a href="https://www.globenewswire.com/Tracker?data=Cw0QajKjRV8ukc1opMIHwNgnAMZFHJVunRcJ2PG1Bt7R2WDjNEvJTMkrMN0cDj_JwEmLGgrksj0djEz7RLSh9sNSmsdv39tLvCEX8vZjqGk=">Mullen Automotive, Inc.</a> (NASDAQ:<a href="https://www.globenewswire.com/Tracker?data=QnpJOHRiS5jAN54a_149nb8xihGUA6K_qjnlAhLvyLagub4EZIZhSTu0YPm9lUt0n-2aQ7iU2laqUw0rYhoY4LEgzByNmMKXjtt_ZRSiPxA="> MULN</a>) ("Mullen" or the "Company"), an electric vehicle ("EV") manufacturer, announces today the Massachusetts Executive Office of Energy and Environmental Affairs' Department of Energy Resources ("DOER") has approved the Company's all-electric Class 1 cargo van, the 2024 Mullen ONE, for up to $3,500 cash voucher under its MOR-EV program.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Aker Horizons

News

Latest news for Aker Horizons (OTC:AKHOF) Stock